Signs
Wasting of the proximal muscles; hypertrophy of others, particularly the calf muscles.
Other presentations
Myoglobinuria. Anaesthetic complications -a dangerous, malignant hyperthermia-like reaction with some anaesthetic agents. Cardiomyopathy may be the first presentation, if muscle weakness is subclinical. There is a higher incidence of learning difficulties, behavioural problems and autistic spectrum disorders, compared with the general population.
Assessment

Investigations
Initial investigations
Serum creatine kinase (CK) -shows moderate-severe increase in BMD (5-50 x normal levels). [2] Raised CK levels in this scenario merit specialist referral for further investigation.
Further investigations
Genetic analysis
Muscle biopsy -for dystrophin staining Genetic tests and counselling for the family Monitoring for cardiomyopathy (see 'Cardiac complications', below).
Differential diagnosis
Other muscular dystrophies: differentiation is by the clinical features such as age of onset and pattern of muscle weakness, by muscle biopsy features and by DNA analysis. Other myopathies -eg, thyrotoxicosis, Cushing's syndrome. Neurological causes of muscle weakness: spinal cord lesions, spinal muscular atrophy, motor neurone disease, multiple sclerosis. These conditions may have additional features such as sensory loss, upper motor neurone signs or muscle fasciculation.
Management
Treatment is supportive and includes:
Exercise programmes and physiotherapy. Recent evidence suggests that exercise training is beneficial. [3] Muscle cramps may be helped by night splints, massage or compression treatment using air-filled boots. Optimise nutrition:
Vitamin D and calcium for bone health. Avoid obesity.
After walking ability is lost -wheelchairs and other aids. Psychological support and employment advice. Monitoring/treatment of complications.
Complications and their management
As with BMD boys, there may be no family history of the disease. Some cases of BMD manifesting carriers were previously diagnosed as having another type of muscular dystrophy but, with new techniques such as dystrophin staining, have been identified as having BMD.
Clinical features
There is wide individual variation in the severity of symptoms -from mild muscle weakness, aches or calf muscle enlargement, to a disease as severe as that in boys. Onset of symptoms can be in adulthood.
There is usually some gradual progression of symptoms with time. Cardiac involvement can occur.
Diagnosis
Muscle biopsy looking at dystrophin is usually helpful. Genetic tests, including X-inactivation patterns.
Management, follow-up and prognosis
This varies depending on individual severity of symptoms.
Further reading & references
